Published in Br J Clin Pharmacol on October 01, 1979
Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax (1982) 1.77
A comparison of lung function methods for assessing dose-response effects of salbutamol. Br J Clin Pharmacol (2004) 1.45
A comparison of plethysmography, spirometry and oscillometry for assessing the pulmonary effects of inhaled ipratropium bromide in healthy subjects and patients with asthma. Br J Clin Pharmacol (2005) 1.03
Asthma outcomes: pulmonary physiology. J Allergy Clin Immunol (2012) 1.02
9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways. J Clin Invest (1987) 1.02
Trials of the bronchodilator activity of the isoenzyme-selective phosphodiesterase inhibitor AH 21-132 in healthy volunteers during a methacholine challenge test. Br J Clin Pharmacol (1992) 0.91
Quantitative analysis of hyperpolarized 3He ventilation changes in mice challenged with methacholine. Magn Reson Med (2010) 0.89
A method for bioassay of potency and effectiveness of inhaled bronchodilators in normal subjects. Br J Clin Pharmacol (1991) 0.82
Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man. Thorax (1991) 0.82
Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma. Respir Res (2007) 0.81
Dose-response relationship and time-course of the effect of inhaled magnesium sulphate on airflow in normal and asthmatic subjects. Br J Clin Pharmacol (1995) 0.81
Assessment of bronchial effects following topical administration of butylamino-phenoxy-propanol-acetate, an oculoselective beta-adrenoceptor blocker in asthmatic subjects. Br J Clin Pharmacol (1992) 0.75
Studies on the bronchodilator, tremorogenic, cardiovascular and hypokalaemic effects of fenoterol dry powder in asthma. Br J Clin Pharmacol (1993) 0.75
A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. J Clin Invest (1956) 14.82
Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med (1968) 7.13
Evaluation of airway interruption technique as a method for measuring pulmonary airflow resistance. J Appl Physiol (1954) 5.30
Mechanical factors in distribution of pulmonary ventilation. J Appl Physiol (1956) 4.81
The relationship between airway resistance, airway conductance and lung volume in subjects of different age and body size. J Clin Invest (1958) 4.71
Stress distribution in lungs: a model of pulmonary elasticity. J Appl Physiol (1970) 4.38
Bronchial hyperreactivity. Br J Dis Chest (1975) 3.70
Oscillation mechanics of lungs and chest in man. J Appl Physiol (1956) 3.63
Pharmacokinetics of inhaled substances. Postgrad Med J (1975) 3.52
Role of autonomic nervous system and the cough reflex in the increased responsiveness of airways in patients with obstructive airway disease. J Clin Invest (1967) 3.09
Acute effects of inhalation of cigarette smoke on airway conductance. J Appl Physiol (1961) 3.08
Effect of a previous deep inspiration on airway resistance in man. J Appl Physiol (1961) 2.72
PARTITIONING OF RESPIRATORY FLOW RESISTANCE IN MAN. J Appl Physiol (1964) 2.30
The assessment of airflow obstruction. Role of measurements of airways resistance and of tests of forced expiration. Br J Dis Chest (1971) 2.22
Physiological factors affecting airway resistance in normal subjects and in patients with obstructive respiratory disease. J Clin Invest (1960) 2.11
A simplified measurement of respiratory resistance by forced oscillation. J Appl Physiol (1970) 2.11
Factors affecting airways conductance: a study of 752 working men. J Appl Physiol (1968) 2.10
Design of a body plethysmograph for studying cardiopulmonary physiology. J Appl Physiol (1959) 2.05
beta-adrenergic agonist resistance in normal human airways. Lancet (1977) 1.91
The mechanical behavior of the lungs in healthy elderly persons. J Clin Invest (1957) 1.85
Variability of plethysmographic measurements of airways resistance in man. J Appl Physiol (1967) 1.84
Variability of routine pulmonary function tests. Thorax (1975) 1.72
Bronchoconstrictor effects of a deep inspiration in patients with asthma. Am Rev Respir Dis (1975) 1.71
The measurement of the viscous resistance of the lung tissues in normal man. Clin Sci (Lond) (1956) 1.68
Quantitative assessment of bronchial beta-adrenoceptor blockade in man. Br J Clin Pharmacol (1979) 1.65
Frequency dependence of flow resistance in patients with obstructive lung disease. J Clin Invest (1968) 1.65
CORRELATIONS, NORMAL STANDARDS, AND INTERDEPENDENCE IN TESTS OF VENTILATORY STRENGTH AND MECHANICS. Am Rev Respir Dis (1964) 1.44
Relative contributions of large and small airways to flow limitation in normal subjects before and after atropine and isoproterenol. J Clin Invest (1977) 1.41
Contribution of compliance of airways to frequency-dependent behavior of lungs. J Appl Physiol (1969) 1.35
MEASUREMENT OF AIRWAY RESISTANCE WITH A VOLUME DISPLACEMENT BODY PLETHYSMOGRAPH. J Appl Physiol (1964) 1.34
Elastic recoil of the lungs in chronic asthmatic patients before and after therapy. J Appl Physiol (1967) 1.32
Changes in specific airways conductance and forced expiratory volume in one second after a bronchodilator in normal subjects and patients with airways obstruction. Thorax (1974) 1.22
Evaluation of the forced oscillation technique for the determination of resistance to breathing. J Clin Invest (1968) 1.20
Effect of age, sex, stature, and smoking habits on human airway conductance. J Appl Physiol (1966) 1.18
Acute effects of inhaled isoproterenol on the mechanical characteristics of the lungs in normal man. J Clin Invest (1970) 1.16
Effect of maximal respiratory manoeuvres on bronchial sensitivity of asthmatic patients as compared to normal people. Br Med J (1975) 1.16
Mechanical consequences of airway smooth muscle relaxation. J Appl Physiol (1971) 1.14
Contributions of loss of lung recoil and of enhanced airways collapsibility to the airflow obstruction of chronic bronchitis and emphysema. J Clin Invest (1973) 1.13
Direct writeout of total respiratory resistance. J Appl Physiol (1970) 1.11
Acute effects of smoking on lung airways resistance in normal and bronchitic subjects. Thorax (1965) 1.09
Extrathoracic airway resistance in man. J Appl Physiol (1961) 1.07
Glottis opening and airway resistance. J Appl Physiol (1972) 1.06
Factors affecting upper airway resistance in conscious man. J Appl Physiol (1971) 1.05
The static elastic properties of the lungs in asthma. Am Rev Respir Dis (1968) 1.05
Assessment of changes in airway calibre I. Tests of forced expiration. Br J Clin Pharmacol (1979) 1.05
Variability of plethysmographic measurements of airway resistance during the day in normal subjects and in patients with bronchial asthma and chronic bronchitis. Respiration (1971) 1.02
Comparative sensitivity of four methods for measuring changes in respiratory flow resistance in man. J Appl Physiol (1971) 1.00
Variation between observers in the estimation of airway resistance and thoracic gas volume. Thorax (1977) 0.98
A comparison of manual and automated methods of measuring airway resistance and thoracic gas volume. Thorax (1977) 0.95
Airway responsiveness to a bronchodilator aerosol. I. Normal human subjects. Am Rev Respir Dis (1974) 0.93
Changes in lung mechanics during asthma induced by exercise. J Appl Physiol (1975) 0.92
Relationships among glottis opening, respiratory flow, and upper airway resistance in humans. J Appl Physiol Respir Environ Exerc Physiol (1977) 0.90
MEASUREMENT OF UPPER AND LOWER AIRWAY RESISTANCE AND CONDUCTANCE IN MAN. J Appl Physiol (1964) 0.86
Measurement of airway variation and bronchial reactivity in normal and asthmatic subjects. Am Rev Respir Dis (1967) 0.85
Evaluation of two techniques for measurement of respiratory resistance by forced oscillation. A study in young subjects with obstructive lung disease. Thorax (1973) 0.84
Body plethysmographic measurements of airway conductance in obstructive pulmonary disease. Am Rev Respir Dis (1969) 0.82
Comparison of airways resistance measurements during panting and quiet breathing. Respiration (1973) 0.80
Lung volumes. Br J Clin Pharmacol (1979) 0.78
Assessment of airway function in children. Bull Physiopathol Respir (Nancy) (1973) 0.78
Variation in airways resistance when defined over different ranges of airflows. Thorax (1978) 0.77
Total respiratory resistance by forced oscillation in normal subjects. Mayo Clin Proc (1976) 0.77
Measurement of respiratory resistance in children by forced oscillations. Am Rev Respir Dis (1972) 0.76
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
Inhaled corticosteroid use and bone-mineral density in patients with asthma. Lancet (2000) 5.66
Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet (1988) 4.85
Asthma, wheezing, and school absence in primary schools. Arch Dis Child (1989) 4.57
Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet (2004) 3.89
Comparison of the systemic effects of fluticasone propionate and budesonide given by dry powder inhaler in healthy and asthmatic subjects. Thorax (2001) 3.23
Validity and repeatability of the IUATLD (1984) Bronchial Symptoms Questionnaire: an international comparison. Eur Respir J (1989) 3.12
Descriptive epidemiology of bronchial reactivity in an adult population: results from a community study. Thorax (1987) 3.06
Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity. N Engl J Med (1969) 2.99
Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ (1993) 2.70
Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet (1990) 2.52
Dietary antioxidant vitamin intake and lung function in the general population. Am J Respir Crit Care Med (1995) 2.25
Assessment and management of asthma in an accident and emergency department. Thorax (1985) 2.21
Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. BMJ (1996) 2.19
Sudden death in asthma: discussion paper. J R Soc Med (1983) 2.13
Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol (1983) 2.10
What symptoms predict the bronchial response to histamine? Evaluation in a community survey of the bronchial symptoms questionnaire (1984) of the International Union Against Tuberculosis and Lung Disease. Int J Epidemiol (1989) 2.05
Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment. Am J Respir Crit Care Med (1999) 2.02
Response to inhaled histamine and 24 hour sodium excretion. Br Med J (Clin Res Ed) (1986) 2.01
Bronchoprotective role for endogenous prostaglandin E2. Lancet (1995) 2.01
The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med (1984) 1.95
beta-adrenergic agonist resistance in normal human airways. Lancet (1977) 1.91
Estimation and repeatability of the response to inhaled histamine in a community survey. Thorax (1987) 1.85
Management of asthma in schools. Arch Dis Child (1987) 1.81
Clinical experience of lymphangioleiomyomatosis in the UK. Thorax (2000) 1.80
Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax (1982) 1.77
Comparison of bronchial reactivity and peak expiratory flow variability measurements for epidemiologic studies. Am Rev Respir Dis (1992) 1.73
Randomised placebo controlled trial of beta agonist dose reduction in asthma. Thorax (1999) 1.68
The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis (1989) 1.66
How patients use domiciliary oxygen. Br Med J (1978) 1.66
Quantitative assessment of bronchial beta-adrenoceptor blockade in man. Br J Clin Pharmacol (1979) 1.65
Comparison of three techniques of inhalation on the airway response to terbutaline. Thorax (1983) 1.64
Comparison of PD20 with two alternative measures of response to histamine challenge in epidemiological studies. Eur Respir J (1993) 1.61
Dosage and delivery of nebulised beta agonists in hospital. Thorax (1983) 1.59
Attitudes and long-term adjustment of patients surviving cardiac arrest. Br Med J (1971) 1.57
Adenosine-induced bronchoconstriction in asthma. Antagonism by inhaled theophylline. Am Rev Respir Dis (1984) 1.52
Step 3 of the asthma guidelines. Thorax (1999) 1.48
Airway and metabolic responsiveness to intravenous salbutamol in asthma: effect of regular inhaled salbutamol. Clin Sci (Lond) (1981) 1.46
Guillain-Barre syndrome associated with Campylobacter infection. Br Med J (Clin Res Ed) (1982) 1.42
Bronchodilator drugs. Pharmacol Ther (1982) 1.39
Asthma induced by suggestion: is it due to airway cooling? Am Rev Respir Dis (1984) 1.38
Adverse effects of oral corticosteroids in relation to dose in patients with lung disease. Thorax (2001) 1.38
Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis (1993) 1.37
Airway and metabolic resistance to intravenous salbutamol: a study in normal man. Clin Sci (Lond) (1980) 1.33
Assessment of bronchial beta blockade after oral bevantolol. Clin Pharmacol Ther (1981) 1.32
Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Thorax (1988) 1.32
Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax (2004) 1.32
Time course of change in bronchial reactivity with an inhaled corticosteroid in asthma. Am Rev Respir Dis (1991) 1.30
High-dose inhaled albuterol in severe chronic airflow limitation. Am Rev Respir Dis (1988) 1.30
A comparison of the Yan and a dosimeter method for methacholine challenge in experienced and inexperienced subjects. Eur Respir J (1991) 1.26
Measurement of bronchial reactivity: a question of interpretation. Thorax (1981) 1.25
Left ventricular pressures in two patients with myocardial infarction. Lancet (1968) 1.24
Effect of long-term treatment with salmeterol on asthma control: a double blind, randomised crossover study. BMJ (1997) 1.20
Effects of beta-adrenergic blockade and stimulation on normal human airways. J Appl Physiol (1973) 1.19
Plasma concentrations of fluticasone propionate and budesonide following inhalation from dry powder inhalers by healthy and asthmatic subjects. Thorax (2003) 1.19
Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study. Thorax (2006) 1.15
Inhaled frusemide and exercise induced asthma: evidence of a role for inhibitory prostanoids. Thorax (1992) 1.14
Asthma control during and after cessation of regular beta 2-agonist treatment. Am Rev Respir Dis (1993) 1.13
Reduced respiratory responses to carbon dioxide after propranolol: a central action. Br Med J (1976) 1.09
Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Thorax (2000) 1.06
Bronchial and cardiac beta-adrenoceptor blockade--a comparison of atenolol, acebutolol and labetalol. Br J Clin Pharmacol (1981) 1.06
Comparison of histamine and methacholine for use in bronchial challenge tests in community studies. Thorax (1988) 1.05
Morbidity from asthma in relation to regular treatment: a community based study. Thorax (1999) 1.05
Effect of beta-adrenergic blockade on respiratory and metabolic responses to exercise. J Appl Physiol Respir Environ Exerc Physiol (1981) 1.04
A single-dose comparison of inhaled albuterol and two formulations of salmeterol on airway reactivity in asthmatic subjects. Am Rev Respir Dis (1991) 1.04
Time course and relative dose potency of systemic effects from salmeterol and salbutamol in healthy subjects. Thorax (1997) 1.03
Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. Eur Respir J (1999) 1.03
Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutaline. Thorax (1997) 1.02
Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study. Thorax (1994) 1.01
Effect of inhaled prostaglandin E2 on bronchial reactivity to sodium metabisulphite and methacholine in patients with asthma. Thorax (1991) 1.01
Chest x-ray film in acute myocardial infarction. Br Med J (1969) 0.99
Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide. Thorax (2004) 0.97
Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge. Am J Respir Crit Care Med (1994) 0.97
Effect of ICI 118551 on bronchial beta-adrenoceptor function and exercise heart rate in normal man. Br J Clin Pharmacol (1983) 0.96
Does measurement of bronchial hyperreactivity help in the clinical diagnosis of asthma? Eur J Respir Dis (1986) 0.96
Systemic effects of salbutamol and salmeterol in patients with asthma. Thorax (1994) 0.95
Microscopic tumour emboli from carcinoma of the prostate. Br J Dis Chest (1982) 0.94
Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man. Br J Clin Pharmacol (1984) 0.93
Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma. Thorax (1991) 0.92
Tolerance to beta-agonists. Bull Eur Physiopathol Respir (1986) 0.92
Who should look after asthma? Thorax (1995) 0.92
Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM (2011) 0.92
Changes in lung mechanics during asthma induced by exercise. J Appl Physiol (1975) 0.92
Action of intravenously administered aminophylline on normal airways. Am Rev Respir Dis (1983) 0.91
Airway response to inhaled salbutamol in hyperthyroid and hypothyroid patients before and after treatment. Thorax (1984) 0.90
Is asthma due to partial beta-blockade of airways? Agents Actions Suppl (1983) 0.89
Changes in pulmonary function 6-12 months after recovery from myocardial infarction. Lancet (1966) 0.89
Airway and cardiovascular responses to inhaled prostacyclin in normal and asthmatic subjects. Am Rev Respir Dis (1985) 0.89
Factors affecting peak expiratory flow variability and bronchial reactivity in a random population sample. Thorax (1993) 0.89
Bronchial beta-adrenoceptor blockade following eyedrops of timolol and its isomer L-714,465 in normal subjects. Br J Clin Pharmacol (1985) 0.88
Effect of salbutamol and ipratropium bromide on airway calibre and bronchial reactivity in asthma and chronic bronchitis. Eur Respir J (1991) 0.88
The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effects. Eur Respir J (1999) 0.88
Effect of single doses of inhaled lignocaine on FEV1 and bronchial reactivity in asthma. Respir Med (1998) 0.87
Adenosine antagonism as an alternative mechanism of action of methylxanthines in asthma. Agents Actions Suppl (1983) 0.87
Effect of sodium-transport inhibitors on airway smooth muscle contractility in vitro. Clin Sci (Lond) (1990) 0.86
Refractoriness to inhaled sodium metabisulphite in subjects with mild asthma. Eur Respir J (1994) 0.86
Effect of regular terbutaline on the airway response to inhaled budesonide. Thorax (1996) 0.86
Modification of bronchial reactivity by physiological concentrations of plasma epinephrine. J Appl Physiol (1985) (1992) 0.85
The effect of lifestyle on wheeze, atopy, and bronchial hyperreactivity in Asian and white children. Am J Respir Crit Care Med (1996) 0.85
The relation between change in airway reactivity and change in respiratory symptoms and medication in a community study. Am Rev Respir Dis (1988) 0.84